SCHEMBL6063217

SCHEMBL6063217

CCCCN(Cc1ccccc1)C(=O)OC(=O)N(CCc1cccc(C)c1)CC(O)c1nc(C(=O)Nc2ccccc2)co1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 3/20 0.39
HDAC6 Q9UBN7 4/20 0.37
HDAC1 Q13547 3/20 0.37
HDAC3 O15379 2/20 0.37
HDAC2 Q92769 2/20 0.37
HDAC4 P56524 1/20 0.37
HDAC7 Q8WUI4 1/20 0.37
HDAC10 Q969S8 1/20 0.37
HDAC11 Q96DB2 1/20 0.37
HDAC8 Q9BY41 1/20 0.37
HDAC9 Q9UKV0 1/20 0.37
HDAC5 Q9UQL6 1/20 0.37
EGFR P00533 1/20 0.35
TAAR1 Q96RJ0 1/20 0.35
POLB P06746 2/20 0.34
NPSR1 Q6W5P4 1/20 0.34
HCRTR1 O43613 2/20 0.34
HCRTR2 O43614 2/20 0.34
TP53 P04637 1/20 0.34
MAPT P10636 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6063113 0.70 FOLH1 (0.36) BACE1TAAR1POLBMAPTNPC1
SCHEMBL11141720 0.62 HDAC6 (0.77) HDAC6HDAC1HDAC3HDAC2HDAC4
SCHEMBL2188007 0.62 HDAC6 (0.56) HDAC6HDAC1HDAC3HDAC2HDAC4
SCHEMBL10891649 0.62 NPC1 (0.58) HDAC6HDAC1HDAC3HDAC2HDAC4
SCHEMBL18961359 0.61 HCRTR2 (0.40) HCRTR1HCRTR2MAPT
SCHEMBL14229247 0.60 GRIN2D (0.51) HDAC6HDAC1HDAC3HDAC2TP53
SCHEMBL13911260 0.60 ALDH1A1 (0.58) HDAC6HDAC1HDAC3HDAC2HDAC4
SCHEMBL9784525 0.59 HDAC6 (0.61) HDAC6HDAC1HDAC3HDAC2HDAC4
SCHEMBL4012599 0.59 HDAC6 (0.56) HDAC6HDAC1HDAC3HDAC2HDAC4
SCHEMBL10952094 0.59 PKM (0.47) HDAC6HDAC1HDAC3HDAC2HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1694357-A1 USE OF CATHEPSIN S INHIBITORS FOR TREATING AN IMMUNE RESPONSE CAUSED BY ADMINISTRATION OF A SMALL MOLECULE THERAPEUTIC OR BIOLOGIC AXYS PHARMACEUTICALS, INC. (US) 2006-08-30 EP disclosed
WO-2005058348-A1 USE OF CATHEPSIN S INHIBITORS FOR TREATING AN IMMUNE RESPONSE CAUSED BY ADMINISTRATION OF A SMALL MOLECULE THERAPEUTIC OR BIOLOGIC AXYS PHARMACEUTICALS, INC. (US) 2005-06-30 WO disclosed